Jagsonpal Pharmaceuticals Limited (BOM:507789)

Elevation Oncology Revenue

Jagsonpal Pharmaceuticals had revenue of 756.12M INR in the quarter ending June 30, 2025, with 23.07% growth. This brings the company's revenue in the last twelve months to 2.83B, up 34.72% year-over-year. In the fiscal year ending March 31, 2025, Jagsonpal Pharmaceuticals had annual revenue of 2.69B with 28.76% growth.

• Revenue (ttm): 2.83B
• Revenue Growth: +34.72%
• P/S Ratio: 6.42
• Revenue / Employee: 2.76M
• Employees: 1,025
• Market Cap: 18.16B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	2.69B	600.14M	28.76%
Mar 31, 2024	2.09B	-280.12M	-11.83%
Mar 31, 2023	2.37B	191.30M	8.79%
Mar 31, 2022	2.18B	296.38M	15.77%
Mar 31, 2021	1.88B	293.78M	18.53%